Kairos Therapeutics is a biopharmaceutical company with a proprietary next-generation antibody-drug conjugate platform based on novel toxin, linker, and site-specific conjugation technology. This technology enables the development of highly efficacious and targeted therapeutics with reduced side-effects. Through key partnerships, Kairos is developing a pipeline of novel antibody-drug conjugate therapeutics for the treatment of multiple forms of cancer.
Company Details
- Founded
- -
- Address
- 2405 Wesbrook Mall, Fourth Floor, Vancouver,bc V6t1z3,canada
- Phone
- (206) 237-1030
- in****@****rks.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- kairostherapeutics.com
- Keywords
- Nanaimo.
- HQ
- Vancouver, BC
Kairos Therapeutics Questions
Kairos Therapeutics's helpline number is (206) 237-1030
Kairos Therapeutics's website is kairostherapeutics.com
Kairos Therapeutics's LinkedIn profile is https://ca.linkedin.com/company/kairos-therapeutics
Kairos Therapeutics's industry is
Biotechnology Research
Kairos Therapeutics's top competitors are
Life Sciences Ontario,
Salix Sciences,
Zymeworks Inc.,
Starfish Neuroscience,
Evolved Therapeutics,
Kairos Pharma,
Kairos Pharma Ltd. (Nyse: Kapa),
Kalos Therapeutics,
Emballages Mitchel-Lincoln Packaging,
Crescita Therapeutics.
Kairos Therapeutics's support email address is info@zymeworks.com
Kairos Therapeutics's categories are Biotechnology Research
Kairos Therapeutics's founding year is 2013
